Evidence map›Paper›PMID 38787434›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.

Vivian S Tan, Michael C Tjong, Wing C Chan, Michael Yan, Victoria Delibasic, Gail Darling, Laura E Davis, Mark Doherty, Julie Hallet, Biniam Kidane and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Vivian S TanDepartment of Radiation Oncology, University of Western Ontario, London, Canada.
Michael C TjongDepartment of Radiation Oncology, University of Toronto, Toronto, Canada.
Wing C ChanICES, Toronto, Canada.
Michael YanDepartment of Radiation Oncology, University of Toronto, Toronto, Canada.
Victoria DelibasicICES, Toronto, Canada.
Gail DarlingDivision of Thoracic Surgery, University of Toronto, Toronto, Canada.
Laura E DavisDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Mark DohertyDivision of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada.
Julie HalletDepartment of Surgery, University of Toronto, Toronto, Canada.
Biniam KidaneDivision of Thoracic Surgery, University of Manitoba, Winnipeg, Canada.
Alyson MaharFaculty of Health Sciences, Queen's University, Kingston, ON, Canada.
Nicole MittmannDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Ambica ParmarDivision of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada.
Hendrick TanDepartment of Radiation Oncology, GenesisCare, Perth, Australia.
Frances C WrightDepartment of Surgery, University of Toronto, Toronto, Canada.
Natalie G CoburnDepartment of Surgery, University of Toronto, Toronto, Canada.
Alexander V LouieDepartment of Radiation Oncology, University of Toronto, Toronto, Canada. alexander.louie@sunnybrook.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePatients with lung cancer can experience significant psychological morbidities including depression. We characterize patterns and factors associated with interventions for symptoms of depression in stage IV non-small cell lung cancer (NSCLC).

methodsWe conducted a population-based cohort study using health services administrative data in Ontario, Canada of stage IV NSCLC diagnosed from January 2007 to September 2018. A positive symptom of depression score was defined by reporting at least one ESAS (Edmonton Symptom Assessment System) depression score ≥ 2 following diagnosis until the end of follow-up (September 2019). Patient factors included age, sex, comorbidity burden, rurality of residence, and neighbourhood income quintile. Interventions included psychiatry assessment, psychology referral, social work referral and anti-depressant medical therapy (for patients ≥ 65 years with universal drug coverage). Multivariable modified Poisson regression models were used to examine the association between patient factors and intervention use for patients who reported symptoms of depression.

resultsIn the cohort of 13,159 patients with stage IV NSCLC lung cancer, symptoms of depression were prevalent (71.4%, n = 9,397). Patients who reported symptoms of depression were more likely to receive psychiatry assessment/psychology referral (7.8% vs 3.5%; SD [standardized difference] 0.19), social work referral (17.4% vs 11.9%; SD 0.16) and anti-depressant prescriptions (23.8% vs 13.8%; SD 0.26) when compared to patients who did not report symptoms of depression respectively. In multivariable analyses, older patients were less likely to receive any intervention. Females were more likely to obtain a psychiatry assessment/psychology referral or social work referral. In addition, patients from non-major urban or rural residences were less likely to receive psychiatry assessment/psychology referral or social work referral, however patients from rural residences were more likely to be prescribed anti-depressants.

conclusionsThere is high prevalence of symptoms of depression in stage IV NSCLC. We identify patient populations, including older patients and rural patients, who are less likely to receive interventions that will help identifying and screening for symptoms of depression.

Indexed as

Carcinoma, Non-Small-Cell LungDepressionLung NeoplasmsAdultAgedAged, 80 and overAntidepressive AgentsCohort StudiesFemaleHumansMaleMiddle AgedNeoplasm StagingOntarioPrevalenceAntidepressive AgentsDepressionNon-small cell lung cancerPatient reported outcomesQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.